About Britt Doolittle

Britt Doolittle is a member of the corporate/M&A, private equity, and healthcare and FDA (US Food and Drug Administration) practice groups at K&L Gates and focuses her practice on healthcare transactions, including M&A, private equity, and general corporate law matters. Britt assists healthcare companies and private equity funds in growing strategically through the purchase and sale of private companies, as well as with commercial contracts and corporate governance. She combines deal-making expertise with an understanding of the regulatory landscape and the healthcare industry to help clients structure transactions, guiding them through the complexities of healthcare transactions.